SAN DIEGO--(BUSINESS WIRE)--Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-shelf neuron ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback